Company Dossier · Health Care
McKesson Corporation
- S&P 500
- Russell 1000
What McKesson Corporation is doing, read from its filings, its own words and the news, with every figure dated and sourced. Not investment advice: no ratings, no price targets.
Open the full company record in Palanor: guidance, KPIs, ownership, calls, prices →
The latest read
Computed from the data on Oct 22, 2026. Every figure links back to its source in the sections below.
- Revenue over the four quarters to June 30, 2026: $411 billion, up 8.8% from a year earlier.SEC EDGAR filings (XBRL)
- Free cash flow (operating cash flow minus capital expenditure) over the four quarters to June 30, 2026: $6.42 billion, up 6.8% from a year earlier.SEC EDGAR filings (XBRL)
- Capital expenditure over the four quarters to June 30, 2026: $0.44 billion, down 19% from a year earlier.SEC EDGAR filings (XBRL)
- Share buybacks in the fiscal year to March 31, 2026: $4.75 billion.SEC EDGAR filings (10-K)
- Long-term debt issued in the fiscal year to March 31, 2026: $1.99 billion.SEC EDGAR filings (10-K)
- Latest earnings call or results release (August 5, 2026): sentiment 0.60 on a −1 to +1 scale (mixed), confidence 0.80 of 1.Palanor Discourse
- Guidance in the last 90 days: 1 outlook figure raised, 0 lowered, 0 held.Guidance Ledger (8-K results releases)
- Latest annual report (filed May 8, 2026): 2 risk factors added, 1 removed.Risk Factor Changes (10-K Item 1A)
- Insiders were net sellers in Q3 2026: $7.1 million on the open market.SEC Form 4
- 2,023 institutional managers reported a position at June 30, 2026 (−27 on the quarter before).SEC Form 13F
- H-1B filings certified in Q2 2026: 44 (46 a year earlier).U.S. Department of Labor (OFLC)
Risk events (12 months): 1 — latest OSHA inspection, Aug 3, 2026 →
Company Posture
How Company Posture is measured →What McKesson Corporation is doing, on three axes, from its filings and its own words, as of 2026-10-22. A description, not a rating: Company Posture never says whether to buy.
Retrenching · Mixed
Expanding ↔ Retrenching
Retrenching
- Capital spending7th pct
- Debt raised64th pct
- Buybacks vs capex2nd pct
- Hiring filings26th pct
- Deals and private raises49th pct
- Patent publications48th pct
Confident ↔ Hedging
Mixed
- Call sentiment44th pct
- Call confidence49th pct
- Guidance changes44th pct
- Risk factors added20th pct
- Insider open-market trades44th pct
- − Risk factors added
- − Call sentiment
- − Guidance changes
Pressure
Components only: Not yet shown as a score: in the back-test it did not add to a naive reader's forecast of impairment, debt acceleration or bankruptcy filings (8-K 2.06, 2.04, 1.03) (not enough events (17 in half 1; needs 20)).
- Fails-to-deliver20th pct
- Stress filings48th pct
Credit
How these are built →McKesson Corporation's borrowing from its SEC filings: the bonds it priced and the debt on its latest balance sheet. A description, not a rating.
Debt on the balance sheet
$9.7B
- Due within a year $1.3B
- Longer term $8.4B
- Default point $5.5B (short + ½ long)
Finance leases included · Jun 30, 2026 filing
Bonds priced, last 12 months
None
U.S. dollar tranches with a term sheet on EDGAR. Deals sold under Rule 144A file none and are not counted.
| Priced | Amount | Coupon | Matures | Spread | Yield |
|---|---|---|---|---|---|
| May 20, 2025 | $650M | 4.650% | 2030 (5y) | +60bp | 4.659% |
| May 20, 2025 | $650M | 4.950% | 2032 (7y) | +70bp | 4.962% |
| May 20, 2025 | $700M | 5.250% | 2035 (10y) | +80bp | 5.279% |
| Sep 5, 2024 | $500M | 4.250% | 2029 (5y) | +72bp | 4.262% |
From the pricing term sheets McKesson Corporation filed with the SEC. Spread is to the benchmark Treasury (or Bund, Gilt) at pricing.
Charts
Live charts: each one redraws from today’s data and has an image link to paste into a document or slide.
Cash flow
Capital returned and raised
What the company says
Hiring and ownership
In the news
Headlines that name McKesson Corporation, with the publisher and a link. The tone is read from each headline’s own words, never from a summary of the article.
- NeutralMcKesson, CD&R near $5 billion Option Care Health acquisition
Palanor Wire · Oct 5, 2026
- NeutralMcKesson, CD&R in talks for $5B deal for Option Care Health: FT
seekingalpha.com · via Marketaux · Oct 5, 2026
- NeutralMcKesson and CD&R near $5bn-plus deal to buy infusion services provider
FT Companies · Oct 5, 2026
- NeutralMcKesson (MCK) Confirms Fiscal 2027 EPS Guidance Amid Solid Valuation Metrics
gurufocus.com · via Marketaux · Oct 1, 2026
- NegativeHackers claim millions of patient records stolen during data breach at healthcare giant McKesson
The company, which distributes medicines and medical devices to hospitals and healthcare practices across the U.S., said it was hacked and expects intermittent service degradation.
TechCrunch · Aug 31, 2026
Filings and records
The last two years of notable 8-Ks, offerings, annual reports, federal awards, lobbying reports, patents and other public records, newest first.
- Oct 20, 2026LobbyingLobbying report (TODD STRATEGY GROUP)third_quarter 2026 · $0.1 million
- Oct 20, 2026LobbyingLobbying report (STANTON PARK GROUP)third_quarter 2026 · $0.1 million
- Oct 20, 2026LobbyingLobbying report (MONUMENT ADVOCACY)third_quarter 2026 · $0.1 million
- Oct 20, 2026LobbyingLobbying report (KOUNTOUPES DENHAM CARR & REID, LLC)third_quarter 2026 · $0.1 million
- Sep 25, 2026Federal awardFederal award from Department of Justice$15.2 million
- Aug 18, 2026Patent
- Aug 11, 2026Patent
- Aug 3, 2026Risk event
- Aug 1, 2026Federal awardFederal award from Department of Veterans Affairs$1,159 million
- Jul 24, 20268-KShareholder vote resultsItem 5.07
- Jul 21, 2026LobbyingLobbying report (TODD STRATEGY GROUP)second_quarter 2026 · $0.1 million
- Jul 20, 2026LobbyingLobbying report (MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP))second_quarter 2026 · $0.5 million
- Jul 20, 2026LobbyingLobbying report (STANTON PARK GROUP)second_quarter 2026 · $0.1 million
- Jul 20, 2026LobbyingLobbying report (KOUNTOUPES DENHAM CARR & REID, LLC)second_quarter 2026 · $0.1 million
- Jul 1, 20268-KDirector or officer changeItem 5.02
- Jul 1, 2026Federal awardFederal award from Department of Veterans Affairs$1,195 million
- Jun 12, 20268-KMaterial agreement signedItem 1.01
- Jun 1, 2026Federal awardFederal award from Department of Veterans Affairs$1,192 million
- Jun 1, 2026Trademark
- May 19, 2026Patent
- May 8, 202610-KAnnual report (10-K)2 risk factors added, 1 removed
- May 5, 2026Patent
- May 1, 2026Federal awardFederal award from Department of Veterans Affairs$1,398 million
- Apr 28, 20268-KMaterial agreement signedItem 1.01
- Apr 28, 20268-KMaterial agreement terminatedItem 1.02
- Apr 6, 20268-KMaterial agreement signedItem 1.01
- Apr 1, 2026Federal awardFederal award from Department of Veterans Affairs$1,191 million
- Mar 19, 2026Trademark
- Mar 13, 2026Trademark
- Mar 5, 20268-KDirector or officer changeItem 5.02
- Feb 10, 2026Patent
- Dec 2, 2025Trademark
- Nov 23, 2025Trademark
- Aug 1, 20258-KShareholder vote resultsItem 5.07
- May 9, 202510-KAnnual report (10-K)0 risk factors added, 1 removed
- May 8, 202410-KAnnual report (10-K)1 risk factors added, 1 removed
Peers
Companies in the same industry in the S&P 500, Russell 1000 or MidCap 400, closest in revenue first. Trailing twelve months, from SEC filings.
| Company | Revenue | Free cash flow | Through |
|---|---|---|---|
| Cencora COR | $333B | $4.1B | Jun 30, 2026 |
| Cardinal Health CAH | $245B | $5.5B | Dec 31, 2025 |
| Henry Schein HSIC | $13.6B | $0.6B | Jun 27, 2026 |
| CVS Health CVS | $415B | $11.8B | Jun 30, 2026 |
| UnitedHealth Group UNH | $450B | $23.6B | Jun 30, 2026 |
| Cigna CI | $282B | — | Jun 30, 2026 |
| Elevance Health ELV | $201B | $6.3B | Jun 30, 2026 |
| Centene Corporation CNC | $179B | $8.9B | Jun 30, 2026 |